3 个月
PsyPost on MSNNicotinamide trial for Alzheimer’s disease shows no clear benefit in reducing tau proteinsNicotinamide emerged as a candidate for investigation ... The treatment was administered in the form of sustained-release ...
In a retrospective cohort study, nicotinamide exposure showed no increased risk for MACE. Prior MACE history, however, was strongly associated with subsequent MACE. To address recent safety ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果